Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 4
2004 2
2005 6
2006 5
2007 4
2008 5
2009 5
2010 2
2011 4
2012 3
2013 3
2014 2
2015 3
2016 5
2017 5
2018 4
2019 8
2020 10
2021 8
2022 6
2023 4
2024 7
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

91 results

Results by year

Filters applied: . Clear all
Page 1
PD-L1 CAR effector cells induce self-amplifying cytotoxic effects against target cells.
Bajor M, Graczyk-Jarzynka A, Marhelava K, Burdzinska A, Muchowicz A, Goral A, Zhylko A, Soroczynska K, Retecki K, Krawczyk M, Klopotowska M, Pilch Z, Paczek L, Malmberg KJ, Wälchli S, Winiarska M, Zagozdzon R. Bajor M, et al. Among authors: walchli s. J Immunother Cancer. 2022 Jan;10(1):e002500. doi: 10.1136/jitc-2021-002500. J Immunother Cancer. 2022. PMID: 35078921 Free PMC article.
CD37 is a safe chimeric antigen receptor target to treat acute myeloid leukemia.
Caulier B, Joaquina S, Gelebart P, Dowling TH, Kaveh F, Thomas M, Tandaric L, Wernhoff P, Katyayini NU, Wogsland C, Gjerstad ME, Fløisand Y, Kvalheim G, Marr C, Kobold S, Enserink JM, Gjertsen BT, McCormack E, Inderberg EM, Wälchli S. Caulier B, et al. Among authors: walchli s. Cell Rep Med. 2024 Jun 18;5(6):101572. doi: 10.1016/j.xcrm.2024.101572. Epub 2024 May 15. Cell Rep Med. 2024. PMID: 38754420 Free PMC article.
ALPL-1 is a target for chimeric antigen receptor therapy in osteosarcoma.
Mensali N, Köksal H, Joaquina S, Wernhoff P, Casey NP, Romecin P, Panisello C, Rodriguez R, Vimeux L, Juzeniene A, Myhre MR, Fåne A, Ramírez CC, Maggadottir SM, Duru AD, Georgoudaki AM, Grad I, Maturana AD, Gaudernack G, Kvalheim G, Carcaboso AM, de Alava E, Donnadieu E, Bruland ØS, Menendez P, Inderberg EM, Wälchli S. Mensali N, et al. Among authors: walchli s. Nat Commun. 2023 Jun 8;14(1):3375. doi: 10.1038/s41467-023-39097-x. Nat Commun. 2023. PMID: 37291203 Free PMC article.
How CAR T Cells Breathe.
Forcados C, Joaquina S, Casey NP, Caulier B, Wälchli S. Forcados C, et al. Among authors: walchli s. Cells. 2022 Apr 25;11(9):1454. doi: 10.3390/cells11091454. Cells. 2022. PMID: 35563759 Free PMC article. Review.
CAR-Ts: new perspectives in cancer therapy.
Abrantes R, Duarte HO, Gomes C, Wälchli S, Reis CA. Abrantes R, et al. Among authors: walchli s. FEBS Lett. 2022 Feb;596(4):403-416. doi: 10.1002/1873-3468.14270. Epub 2022 Jan 12. FEBS Lett. 2022. PMID: 34978080 Free article. Review.
Pharmacologic Control of CAR T Cells.
Caulier B, Enserink JM, Wälchli S. Caulier B, et al. Among authors: walchli s. Int J Mol Sci. 2021 Apr 21;22(9):4320. doi: 10.3390/ijms22094320. Int J Mol Sci. 2021. PMID: 33919245 Free PMC article. Review.
Efficient CAR T cell targeting of the CA125 extracellular repeat domain of MUC16.
Casey NP, Kleinmanns K, Forcados C, Gelebart PF, Joaquina S, Lode M, Benard E, Kaveh F, Caulier B, Helgestad Gjerde C, García de Jalón E, Warren DJ, Lindemann K, Rokkones E, Davidson B, Myhre MR, Kvalheim G, Bjørge L, McCormack E, Inderberg EM, Wälchli S. Casey NP, et al. Among authors: walchli s. J Immunother Cancer. 2024 Apr 11;12(4):e008179. doi: 10.1136/jitc-2023-008179. J Immunother Cancer. 2024. PMID: 38604812 Free PMC article.
CD20 expression regulates CD37 levels in B-cell lymphoma - implications for immunotherapies.
Bobrowicz M, Kusowska A, Krawczyk M, Zhylko A, Forcados C, Slusarczyk A, Barankiewicz J, Domagala J, Kubacz M, Šmída M, Dostalova L, Marhelava K, Fidyt K, Pepek M, Baranowska I, Szumera-Cieckiewicz A, Inderberg EM, Wälchli S, Granica M, Graczyk-Jarzynka A, Majchrzak M, Poreba M, Gehlert CL, Peipp M, Firczuk M, Prochorec-Sobieszek M, Winiarska M. Bobrowicz M, et al. Among authors: walchli s. Oncoimmunology. 2024 Jun 4;13(1):2362454. doi: 10.1080/2162402X.2024.2362454. eCollection 2024. Oncoimmunology. 2024. PMID: 38846084 Free PMC article.
Treating osteosarcoma with CAR T cells.
Köksal H, Müller E, Inderberg EM, Bruland Ø, Wälchli S. Köksal H, et al. Among authors: walchli s. Scand J Immunol. 2019 Mar;89(3):e12741. doi: 10.1111/sji.12741. Epub 2019 Jan 15. Scand J Immunol. 2019. PMID: 30549299 Free article. Review.
Combinatorial CAR design improves target restriction.
Köksal H, Dillard P, Juzeniene A, Kvalheim G, Smeland EB, Myklebust JH, Inderberg EM, Wälchli S. Köksal H, et al. Among authors: walchli s. J Biol Chem. 2021 Jan-Jun;296:100116. doi: 10.1074/jbc.RA120.016234. Epub 2020 Dec 3. J Biol Chem. 2021. PMID: 33234592 Free PMC article.
91 results